Nintedanib

img 
Name: Nintedanib
CAS#: 656247-17-5 (free base)
Chemical Formula: C31H33N5O4
Exact Mass: 539.25325
Molecular Weight: 539.62
Elemental Analysis: C, 69.00; H, 6.16; N, 12.98; O, 11.86
Description: Nintedanib, also known as BIBF 1120, is an orally bioavailable inhibitor of vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR). Intedanib selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the induction of endothelial cell apoptosis; a reduction in tumor vasculature; and the inhibition of tumor cell proliferation and migration. On 11/15/2014 , FDA approved Nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF).

Leave a Reply

Your email address will not be published. Required fields are marked *